{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:04Z","timestamp":1791928684822,"version":"4.3.4"},"reference-count":39,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"12","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,10,30]]},"DOI":"10.1167\/iovs.17-23632","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T12:14:56Z","timestamp":1541074496000},"page":"5266","source":"Crossref","is-referenced-by-count":35,"title":["Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection"],"prefix":"10.1167","volume":"59","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojjat","family":"Bazzazi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Lima e Silva","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan B.","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States"},{"name":"Wilmer Eye Institute, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Campochiaro","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander S.","family":"Popel","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-12-5266-b01","doi-asserted-by":"crossref","unstructured":"Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA. 2004; 291: 1900\u20131901.","DOI":"10.1001\/jama.291.15.1900"},{"key":"i1552-5783-59-12-5266-b02","doi-asserted-by":"crossref","unstructured":"Campochiaro PA. Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res. 2015; 49: 67\u201381.","DOI":"10.1016\/j.preteyeres.2015.06.002"},{"key":"i1552-5783-59-12-5266-b03","doi-asserted-by":"crossref","unstructured":"Ohno-Matsui K, Morita I, Tombran-Tink J, et al. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol. 2001; 189: 323\u2013333.","DOI":"10.1002\/jcp.10026"},{"key":"i1552-5783-59-12-5266-b04","doi-asserted-by":"crossref","unstructured":"Patel SR, Berezovsky DE, McCarey BE, Zarnitsyn V, Edelhauser HF, Prausnitz MR. Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci. 2012; 53: 4433\u20134441.","DOI":"10.1167\/iovs.12-9872"},{"key":"i1552-5783-59-12-5266-b05","doi-asserted-by":"crossref","unstructured":"Chiang B, Wang K, Ethier CR, Prausnitz MR. Clearance kinetics and clearance routes of molecules from the suprachoroidal space after microneedle injection. Invest Ophthalmol Vis Sci. 2017; 58: 545\u2013554.","DOI":"10.1167\/iovs.16-20679"},{"key":"i1552-5783-59-12-5266-b06","doi-asserted-by":"crossref","unstructured":"Chiang B, Venugopal N, Grossniklaus HE, Jung JH, Edelhauser HF, Prausnitz MR. Thickness and closure kinetics of the suprachoroidal space following microneedle injection of liquid formulations. Invest Ophthalmol Vis Sci. 2017; 58: 555\u2013564.","DOI":"10.1167\/iovs.16-20377"},{"key":"i1552-5783-59-12-5266-b07","doi-asserted-by":"crossref","unstructured":"Chen M, Li X, Liu J, Han Y, Cheng L. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model. J Control Release. 2015; 203: 109\u2013117.","DOI":"10.1016\/j.jconrel.2015.02.021"},{"key":"i1552-5783-59-12-5266-b08","doi-asserted-by":"crossref","unstructured":"Willoughby AS, Vuong VS, Cunefare D, et al. Choroidal changes after suprachoroidal injection of triamcinolone acetonide in eyes with macular edema secondary to retinal vein occlusion. Am J Ophthalmol. 2018; 186: 144\u2013151.","DOI":"10.1016\/j.ajo.2017.11.020"},{"key":"i1552-5783-59-12-5266-b09","doi-asserted-by":"crossref","unstructured":"Ferrara N, Damico L, Shams N, Lowman H, Kim R. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina. 2006; 26: 859\u2013870.","DOI":"10.1097\/01.iae.0000242842.14624.e7"},{"key":"i1552-5783-59-12-5266-b10","doi-asserted-by":"crossref","unstructured":"Spaide RF, Laud K, Fine HF, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina. 2006; 26: 383\u2013390.","DOI":"10.1097\/01.iae.0000238561.99283.0e"},{"key":"i1552-5783-59-12-5266-b11","doi-asserted-by":"crossref","unstructured":"Karagiannis ED, Popel AS. A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells. Proc Natl Acad Sci U S A. 2008; 105: 13775\u201313780.","DOI":"10.1073\/pnas.0803241105"},{"key":"i1552-5783-59-12-5266-b12","doi-asserted-by":"crossref","unstructured":"Shmueli RB, Ohnaka M, Miki A, et al. Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide. Biomaterials. 2013; 34: 7544\u20137551.","DOI":"10.1016\/j.biomaterials.2013.06.044"},{"key":"i1552-5783-59-12-5266-b13","doi-asserted-by":"crossref","unstructured":"Lima e Silva R, Kanan Y, Mirando AC, et al . Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage. Sci Transl Med. 2017; 9: eaai8030.","DOI":"10.1126\/scitranslmed.aai8030"},{"key":"i1552-5783-59-12-5266-b14","doi-asserted-by":"crossref","unstructured":"Balachandran RK, Barocas VH. Computer modeling of drug delivery to the posterior eye: effect of active transport and loss to choroidal blood flow. Pharm Res. 2008; 25: 2685\u20132696.","DOI":"10.1007\/s11095-008-9691-3"},{"key":"i1552-5783-59-12-5266-b15","doi-asserted-by":"crossref","unstructured":"Jooybar E, Abdekhodaie MJ, Farhadi F, Cheng YL. Computational modeling of drug distribution in the posterior segment of the eye: effects of device variables and positions. Math Biosci. 2014; 255: 11\u201320.","DOI":"10.1016\/j.mbs.2014.06.008"},{"key":"i1552-5783-59-12-5266-b16","doi-asserted-by":"crossref","unstructured":"Kavousanakis ME, Kalogeropoulos NG, Hatziavramidis DT. Computational modeling of drug delivery to the posterior eye. Chem Eng Sci. 2014; 108: 203\u2013212.","DOI":"10.1016\/j.ces.2014.01.005"},{"key":"i1552-5783-59-12-5266-b17","doi-asserted-by":"crossref","unstructured":"Kotha S, Murtomaki L. Virtual pharmacokinetic model of human eye. Math Biosci. 2014; 253: 11\u201318.","DOI":"10.1016\/j.mbs.2014.03.014"},{"key":"i1552-5783-59-12-5266-b18","doi-asserted-by":"crossref","unstructured":"Park J, Bungay PM, Lutz RJ, et al. Evaluation of coupled convective-diffusive transport of drugs administered by intravitreal injection and controlled release implant. J Control Release. 2005; 105: 279\u2013295.","DOI":"10.1016\/j.jconrel.2005.03.010"},{"key":"i1552-5783-59-12-5266-b19","doi-asserted-by":"crossref","unstructured":"Haghjou N, Abdekhodaie MJ, Cheng YL. Retina-choroid-sclera permeability for ophthalmic drugs in the vitreous to blood direction: quantitative assessment. Pharm Res. 2013; 30: 41\u201359.","DOI":"10.1007\/s11095-012-0847-9"},{"key":"i1552-5783-59-12-5266-b20","doi-asserted-by":"crossref","unstructured":"Ranta VP, Mannermaa E, Lummepuro K, et al. Barrier analysis of periocular drug delivery to the posterior segment. J Control Release. 2010; 148: 42\u201348.","DOI":"10.1016\/j.jconrel.2010.08.028"},{"key":"i1552-5783-59-12-5266-b21","doi-asserted-by":"crossref","unstructured":"Hutton-Smith LA, Gaffney EA, Byrne HM, Maini PK, Gadkar K, Mazer NA. Ocular pharmacokinetics of therapeutic antibodies given by intravitreal injection: estimation of retinal permeabilities using a 3-compartment semi-mechanistic model. Mol Pharm. 2017; 14: 2690\u20132696.","DOI":"10.1021\/acs.molpharmaceut.7b00164"},{"key":"i1552-5783-59-12-5266-b22","doi-asserted-by":"crossref","unstructured":"Del Amo EM, Rimpela AK, Heikkinen E, et al. Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res. 2017; 57: 134\u2013185.","DOI":"10.1016\/j.preteyeres.2016.12.001"},{"key":"i1552-5783-59-12-5266-b23","doi-asserted-by":"crossref","unstructured":"Dickmann LJ, Yip V, Li C, et al. Evaluation of fluorophotometry to assess the vitreal pharmacokinetics of protein therapeutics. Invest Ophthalmol Vis Sci. 2015; 56: 6991\u20136999.","DOI":"10.1167\/iovs.15-17457"},{"key":"i1552-5783-59-12-5266-b24","doi-asserted-by":"crossref","unstructured":"Mac Gabhann F, Demetriades AM, Deering T, et al. Protein transport to choroid and retina following periocular injection: theoretical and experimental study. Ann Biomed Eng. 2007; 35: 615\u2013630.","DOI":"10.1007\/s10439-006-9238-x"},{"key":"i1552-5783-59-12-5266-b25","doi-asserted-by":"crossref","unstructured":"Missel PJ. Simulating intravitreal injections in anatomically accurate models for rabbit, monkey, and human eyes. Pharm Res. 2012; 29: 3251\u20133272.","DOI":"10.1007\/s11095-012-0721-9"},{"key":"i1552-5783-59-12-5266-b26","unstructured":"Tsuboi S, Pederson JE. Permeability of the isolated dog retinal pigment epithelium to carboxyfluorescein. Invest Ophthalmol Vis Sci. 1986; 27: 1767\u20131770."},{"key":"i1552-5783-59-12-5266-b27","unstructured":"Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000; 41: 1181\u20131185."},{"key":"i1552-5783-59-12-5266-b28","doi-asserted-by":"crossref","unstructured":"el-Kareh AW, Braunstein SL, Secomb TW. Effect of cell arrangement and interstitial volume fraction on the diffusivity of monoclonal antibodies in tissue. Biophys J. 1993; 64: 1638\u20131646.","DOI":"10.1016\/S0006-3495(93)81532-7"},{"key":"i1552-5783-59-12-5266-b29","doi-asserted-by":"crossref","unstructured":"Pitkanen L, Ranta VP, Moilanen H, Urtti A. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest Ophthalmol Vis Sci. 2005; 46: 641\u2013646.","DOI":"10.1167\/iovs.04-1051"},{"key":"i1552-5783-59-12-5266-b30","doi-asserted-by":"crossref","unstructured":"Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol. 1999; 128: 739\u2013746.","DOI":"10.1016\/S0002-9394(99)00239-1"},{"key":"i1552-5783-59-12-5266-b31","unstructured":"Bozkir G, Bozkir M, Dogan H, Aycan K, Guler B. Measurements of axial length and radius of corneal curvature in the rabbit eye. Acta Med Okayama. 1997; 51: 9\u201311."},{"key":"i1552-5783-59-12-5266-b32","doi-asserted-by":"crossref","unstructured":"Kalvoda J, Duskova J, Kubena A, Povysil C, Kalvodova B. Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2009; 247: 1307\u20131314.","DOI":"10.1007\/s00417-009-1100-z"},{"key":"i1552-5783-59-12-5266-b33","doi-asserted-by":"crossref","unstructured":"Falkenstein IA, Cheng L, Freeman WR. Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin). Retina. 2007; 27: 1044\u20131047.","DOI":"10.1097\/IAE.0b013e3180592ba6"},{"key":"i1552-5783-59-12-5266-b34","doi-asserted-by":"crossref","unstructured":"Su X, Vesco C, Fleming J, Choh V. Density of ocular components of the bovine eye. Optom Vis Sci. 2009; 86: 1187\u20131195.","DOI":"10.1097\/OPX.0b013e3181baaf4e"},{"key":"i1552-5783-59-12-5266-b35","doi-asserted-by":"crossref","unstructured":"Cabaleiro JM, Laborde C, Artana G. Interaction between a laminar starting immersed micro-jet and a parallel wall. Phys Fluids. 2015; 27: 013601.","DOI":"10.1063\/1.4905037"},{"key":"i1552-5783-59-12-5266-b36","doi-asserted-by":"crossref","unstructured":"Damian IR, Marculescu C, Balan C. Experiments and Numerical Simulations of Vortex Ring Formation in Microgeometries. Int Symp AdvTopics Elect Eng (Atee). 2015; 585\u2013590.","DOI":"10.1109\/ATEE.2015.7133874"},{"key":"i1552-5783-59-12-5266-b37","doi-asserted-by":"crossref","unstructured":"Berman ER, Michaelson IC. The chemical composition of the human vitreous body as related to age and myopia. Exp Eye Res. 1964; 3: 9\u201315.","DOI":"10.1016\/S0014-4835(64)80003-8"},{"key":"i1552-5783-59-12-5266-b38","doi-asserted-by":"crossref","unstructured":"Neal RE, Bettelheim FA, Lin C, Winn KC, Garland DL, Zigler JS Jr. Alterations in human vitreous humour following cataract extraction. Exp Eye Res. 2005; 80: 337\u2013347.","DOI":"10.1016\/j.exer.2004.09.015"},{"key":"i1552-5783-59-12-5266-b39","unstructured":"Smith RT, Koester CJ, Campbell CJ. Vitreous fluorophotometer data analysis by deconvolution. Invest Ophthalmol Vis Sci. 1986; 27: 406\u2013414."}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2712198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:58Z","timestamp":1791927058000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.17-23632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.17-23632","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,30]]}}}